reviewNature Reviews Drug DiscoveryMay 30, 2008Closed access

Drug development of MET inhibitors: targeting oncogene addiction and expedience

PMPaolo M. ComoglioSGSilvia GiordanoLTLivio Trusolino

University of Turin · Candiolo Cancer Institute

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

820
total citations
FWCI
34.39
Percentile
100%
References
140
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Oncogene
  • Cancer research
  • Tyrosine kinase
  • Cancer
  • Angiogenesis
  • Drug
  • Drug development
  • Medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.